These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9161791)

  • 1. Adoptive immunotherapy with donor lymphocyte transfusions.
    Kolb HJ; Holler E
    Curr Opin Oncol; 1997 Mar; 9(2):139-45. PubMed ID: 9161791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients.
    Kolb HJ; Schattenberg A; Goldman JM; Hertenstein B; Jacobsen N; Arcese W; Ljungman P; Ferrant A; Verdonck L; Niederwieser D; van Rhee F; Mittermueller J; de Witte T; Holler E; Ansari H;
    Blood; 1995 Sep; 86(5):2041-50. PubMed ID: 7655033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
    Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
    Clin Transpl; 1996; ():281-90. PubMed ID: 9286578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adoptive immunotherapy in chimeras with donor lymphocytes.
    Kolb HJ; Schmid C; Chen X; Woiciechowski A; Roskrow M; Weber M; Guenther W; Ledderose G; Schleuning M
    Acta Haematol; 2003; 110(2-3):110-20. PubMed ID: 14583671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoptive immunotherapy in canine chimeras.
    Kolb HJ; Günther W; Schumm M; Holler E; Wilmanns W; Thierfelder S
    Transplantation; 1997 Feb; 63(3):430-6. PubMed ID: 9039935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adoptive immunotherapy with haploidentical allogeneic peripheral blood lymphocytes following autologous bone marrow transplantation.
    Nagler A; Ackerstein A; Or R; Naparstek E; Slavin S
    Exp Hematol; 2000 Nov; 28(11):1225-31. PubMed ID: 11063870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graft-versus-leukemia and graft-versus-lymphoma effects of allogeneic bone marrow transplantation and of allogeneic donor leukocyte transfusions.
    Vandenberghe P; Boogaerts MA
    Ann Hematol; 1995 Nov; 71(5):209-17. PubMed ID: 7492623
    [No Abstract]   [Full Text] [Related]  

  • 8. Graft-versus-host reactions: anti-leukemia effects of donor T cells.
    Flowers ME; Sullivan KM; Deeg HJ
    Transplant Proc; 1996 Jun; 28(3):1184-5. PubMed ID: 8658620
    [No Abstract]   [Full Text] [Related]  

  • 9. Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells.
    Verdonck LF; Petersen EJ; Lokhorst HM; Nieuwenhuis HK; Dekker AW; Tilanus MG; de Weger RA
    Bone Marrow Transplant; 1998 Dec; 22(11):1057-63. PubMed ID: 9877267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cells, graft-versus-host disease and graft-versus-leukemia: innovative approaches for blood and marrow transplantation.
    Champlin R; Giralt S; Gajewski J
    Acta Haematol; 1996; 95(3-4):157-63. PubMed ID: 8677736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graft-versus-leukemia effects of transplantation and donor lymphocytes.
    Kolb HJ
    Blood; 2008 Dec; 112(12):4371-83. PubMed ID: 19029455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
    Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
    J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor leukocyte transfusions for treatment of leukemic relapse after bone marrow transplantation. EBMT Immunology and Chronic Leukemia Working Parties.
    Kolb HJ
    Vox Sang; 1998; 74 Suppl 2():321-9. PubMed ID: 9704463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
    Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
    Johnson BD; Drobyski WR; Truitt RL
    Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes.
    Lee HC; Saliba RM; Rondon G; Chen J; Charafeddine Y; Medeiros LJ; Alatrash G; Andersson BS; Popat U; Kebriaei P; Ciurea S; Oran B; Shpall E; Champlin R
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1948-54. PubMed ID: 26183077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoptive immunotherapy following allogeneic bone marrow transplantation.
    Dazzi F; Goldman JM
    Annu Rev Med; 1998; 49():329-40. PubMed ID: 9509267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoptive immunotherapy in human and canine chimeras--the role of interferon alfa. EBMT Chronic Leukemia Working Party.
    Kolb HJ; Mittermüller J; Hertenstein H; Schumm M; Holler E; de Witte T; Günther W; Ljungman P; Goldman JM
    Semin Hematol; 1993 Jul; 30(3 Suppl 3):37-9. PubMed ID: 8235705
    [No Abstract]   [Full Text] [Related]  

  • 19. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-state analysis illustrates treatment success after stem cell transplantation for acute myeloid leukemia followed by donor lymphocyte infusion.
    Eefting M; de Wreede LC; Halkes CJ; von dem Borne PA; Kersting S; Marijt EW; Veelken H; Putter H; Schetelig J; Falkenburg JH
    Haematologica; 2016 Apr; 101(4):506-14. PubMed ID: 26802054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.